chr7-93101374-C-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_017654.4(SAMD9):​c.4724G>A​(p.Gly1575Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00168 in 1,613,358 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1575V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 3 hom. )

Consequence

SAMD9
NM_017654.4 missense

Scores

6
7
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:2

Conservation

PhyloP100: 5.51
Variant links:
Genes affected
SAMD9 (HGNC:1348): (sterile alpha motif domain containing 9) This gene encodes a sterile alpha motif domain-containing protein. The encoded protein localizes to the cytoplasm and may play a role in regulating cell proliferation and apoptosis. Mutations in this gene are the cause of normophosphatemic familial tumoral calcinosis. Alternate splicing results in multiple transcript variants that encode the same protein.[provided by RefSeq, Jul 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.05644813).
BP6
Variant 7-93101374-C-T is Benign according to our data. Variant chr7-93101374-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 709973.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0012 (183/152038) while in subpopulation NFE AF= 0.00134 (91/67942). AF 95% confidence interval is 0.00112. There are 0 homozygotes in gnomad4. There are 105 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 3 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SAMD9NM_017654.4 linkuse as main transcriptc.4724G>A p.Gly1575Glu missense_variant 3/3 ENST00000379958.3
SAMD9NM_001193307.2 linkuse as main transcriptc.4724G>A p.Gly1575Glu missense_variant 2/2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SAMD9ENST00000379958.3 linkuse as main transcriptc.4724G>A p.Gly1575Glu missense_variant 3/31 NM_017654.4 P1
SAMD9ENST00000620985.4 linkuse as main transcriptc.4724G>A p.Gly1575Glu missense_variant 2/22 P1

Frequencies

GnomAD3 genomes
AF:
0.00120
AC:
183
AN:
152038
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00659
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00134
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00166
AC:
418
AN:
251144
Hom.:
0
AF XY:
0.00162
AC XY:
220
AN XY:
135746
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.000595
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00813
Gnomad NFE exome
AF:
0.00192
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00173
AC:
2522
AN:
1461320
Hom.:
3
Cov.:
32
AF XY:
0.00167
AC XY:
1213
AN XY:
726972
show subpopulations
Gnomad4 AFR exome
AF:
0.000149
Gnomad4 AMR exome
AF:
0.000134
Gnomad4 ASJ exome
AF:
0.000268
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00863
Gnomad4 NFE exome
AF:
0.00178
Gnomad4 OTH exome
AF:
0.00116
GnomAD4 genome
AF:
0.00120
AC:
183
AN:
152038
Hom.:
0
Cov.:
32
AF XY:
0.00141
AC XY:
105
AN XY:
74268
show subpopulations
Gnomad4 AFR
AF:
0.000338
Gnomad4 AMR
AF:
0.000524
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00659
Gnomad4 NFE
AF:
0.00134
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000951
Hom.:
0
Bravo
AF:
0.000680
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.00163
AC:
198
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00175
EpiControl
AF:
0.00130

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3Benign:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxMay 30, 2024In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 28545555) -
Uncertain significance, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Uncertain significance, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoAug 24, 2021DNA sequence analysis of the SAMD9 gene demonstrated a sequence change, c.4724G>A, in exon 3 that results in an amino acid change, p.Gly1575Glu. This sequence change does not appear to have been previously described in patients with SAMD9-related disorders. This sequence change has been described in the gnomAD database with a population frequency of 0.83% in the Finnish subpopulation (dbSNP rs148724199). The p.Gly1575Glu change affects a moderately conserved amino acid residue located in a domain of the SAMD9 protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Gly1575Glu substitution. Due to this insufficient evidence and the lack of functional studies, the clinical significance of the p.Gly1575Glu change remains unknown at this time. -
SAMD9-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesAug 19, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.96
BayesDel_addAF
Benign
-0.073
T
BayesDel_noAF
Uncertain
0.11
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.28
T;T
Eigen
Pathogenic
0.74
Eigen_PC
Pathogenic
0.70
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.83
T;.
M_CAP
Benign
0.039
D
MetaRNN
Benign
0.056
T;T
MetaSVM
Uncertain
0.26
D
MutationAssessor
Uncertain
2.5
M;M
MutationTaster
Benign
1.0
D
PrimateAI
Uncertain
0.64
T
PROVEAN
Pathogenic
-6.2
.;D
REVEL
Pathogenic
0.76
Sift
Uncertain
0.0010
.;D
Sift4G
Uncertain
0.0040
D;D
Polyphen
1.0
D;D
Vest4
0.82
MVP
0.87
MPC
0.75
ClinPred
0.077
T
GERP RS
4.4
Varity_R
0.89
gMVP
0.95

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs148724199; hg19: chr7-92730687; COSMIC: COSV101180408; COSMIC: COSV101180408; API